FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology and concerns applications of dihydrochloride hydrazide 2-[1-(thietanyl-3)benzimidazolyl-2-thio]acetic acid as a haemostasis system corrector - inhibitor of adhesive aggregative function of thrombocytes to prevent pathological thrombosis.
EFFECT: invention provides high effective inhibition of thrombosis.
2 tbl 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-METHYL-8-PIPERAZINE-7-(THIETHANYL-3)-1-ETHYLXANTHINE HYDROCHLORIDE, EXHIBITING ANTIAGGREGANT AND DISAGGREGATION ACTIVITY | 2009 |
|
RU2404181C1 |
| METHOD OF ASSESSING THE EFFICIENCY OF ANTI-CLEGGANT MEDICINAL PRODUCT IN WHOLE PERIPHERAL BLOOD SAMPLES | 2022 |
|
RU2800671C1 |
| REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
| CYCLOPHILIN A - AGENT ENHANCING THROMBOCYTE ADHESION PROPERTIES | 2010 |
|
RU2435607C1 |
| METHOD FOR ADJUSTING HEMORHEOLOGIC DISORDERS IN CARDIAC ISCHEMIA PATIENTS | 2004 |
|
RU2292861C2 |
| PRODUCT WITH ANTIAGGREGATION AND ANTICOAGULANT EFFECTS, AND METHOD OF ITS PREPARATION | 2023 |
|
RU2808110C1 |
| METHOD FOR QUANTITATIVE ASSESSMENT OF THROMBOCYTE AGGREGATION ACTIVITY IN PATIENTS WITH NEW CORONAVIRAL INFECTION | 2021 |
|
RU2760095C1 |
| METHOD OF EARLY PREDICTION OF RISK OF DEVELOPING VASCULAR INVOLVEMENTS IN ONSET OF ENDOCRINOPATHIES | 2010 |
|
RU2426123C1 |
| METHOD OF DETERMINING PLATELET RESISTANCE TO ACETYLSALICYLIC ACID | 2013 |
|
RU2538219C2 |
| METHOD OF DETERMINING AGREGATIVE ACTIVITY OF PLATELETS AND DEVICE FOR ITS REALISATION | 2008 |
|
RU2391665C1 |
